论文部分内容阅读
随着人类基因组研究的深入,冠心病患者将会不同程度受益于基因治疗的进步。有研究者提出了“治疗性血管生成(therapeutic angiogenesis)”这一治疗策略[1]。很快,治疗性血管生成就成了冠心病治疗研究中的热点之一。其中,两种重要的促血管生成因子,血管内皮生长因子(vascular en
With the deepening of human genome research, patients with coronary heart disease will benefit from gene therapy in varying degrees. Some researchers put forward the therapeutic angiogenesis (therapeutic angiogenesis) this treatment strategy [1]. Soon, therapeutic angiogenesis has become one of the hot spots in the study of coronary heart disease. Among them, two important pro-angiogenic factors, vascular endothelial growth factor (vascular en